JPS6116258B2 - - Google Patents

Info

Publication number
JPS6116258B2
JPS6116258B2 JP14637979A JP14637979A JPS6116258B2 JP S6116258 B2 JPS6116258 B2 JP S6116258B2 JP 14637979 A JP14637979 A JP 14637979A JP 14637979 A JP14637979 A JP 14637979A JP S6116258 B2 JPS6116258 B2 JP S6116258B2
Authority
JP
Japan
Prior art keywords
mixture
formula
acid
compound
add
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP14637979A
Other languages
Japanese (ja)
Other versions
JPS5566535A (en
Inventor
Furetsudo De Horo Kaaru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Givaudan SA
Original Assignee
L Givaudan and Co SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L Givaudan and Co SA filed Critical L Givaudan and Co SA
Publication of JPS5566535A publication Critical patent/JPS5566535A/en
Publication of JPS6116258B2 publication Critical patent/JPS6116258B2/ja
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35Ketones, e.g. benzophenone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は光遮蔽剤に関する。 太陽光線が皮膚の老化を促し、この望ましくな
い効果は初め、約320nm〜40nmの範囲の波長を
有する紫外A−線が直接皮膚を日焼けさせること
により起ることは知れている。 本発明により4−(1,1−ジメチルエチル)−
4′−メトキシジベンゾイルメタン、すなわち式 を有する化合物は優れた紫外A線フイルターで、
皮膚の老化をかなり防ぎ、すばらしい皮膚許容性
と安定性(光、熱及び湿気)があることが判つ
た。 本発明によれば、式の化合物の最大吸収は約
330nm〜360nmの範囲であり、290nm〜320nmの
範囲にはないが、この約290nm〜320nmの範囲に
おいて、紅斑をおこす紫外B線を吸収する物質で
ある紫外B線フイルターの保護作用を式の化合
物は向上することも判つた。 本発明は前記の知見に基ずき、またひとつの観
点は、前記式の化合物、望ましくは紫外B線フ
イルターを組合せたものを含む光遮蔽剤に関す
る。本発明の別の特長は、式の化合物を、望ま
しくは紫外B線フイルターと一緒に光遮蔽剤に用
いることに関する。 光遮蔽剤が、紫外B線フイルターと共に式の
化合物を含めば、280nm〜380nmの範囲の紫外線
を完全に吸収(いわゆる「A+B完全遮蔽」)
し、そして皮膚を早期の老化及び多くの場合光に
よる皮膚炎から守る。 本発明による光遮蔽剤、特に日常の化粧品用の
皮膚保護製剤の製造は、式の化合物を、望まし
くは紫外B線フイルターと組合せて、通常の光遮
蔽剤用化粧品基剤に混合しておこなう。 本発明の範囲の紫外B線フイルター、即ち約
290nm〜320nmの間に最大吸収を有する物質とし
ては、次のような種々の物質のクラスに属する有
機化合物を一般的な紫外B線フイルターとして挙
げることができる。 (1) p−アミノ安息香酸誘導体、例えばp−アミ
ノ安息香酸エチル、その他のエステル類(p−
アミノ安息香酸プロピル、p−アミノ安息香酸
ブチル、及びp−アミノ安息香酸イソブチルな
ど)p−ジメチルアミノ安息香酸エチル、p−
アミノ安息香酸グリセリル、及びp−ジメチル
アミノ安息香酸アミル。 (2) 桂皮酸誘導体、例えば2−エトキシエチルp
−メトキシ桂皮酸エステル、2−エチルヘキシ
ルp−メトキシ桂皮酸エステル、p−メトキシ
桂皮酸エステル混合物及び桂皮酸エステル混合
物。 (3) ジベンズアラジン。 (4) 複素環式窒素含有化合物、例えば2−フエニ
ルベンズイミダゾール誘導体(例えば2−フエ
ニルベンズイミダゾール−5−スルホン酸)。 (5) サリチル酸誘導体、例えばサリチル酸メンチ
ルエステル、サリチル酸ホモメンチルエステル
及びサルチル酸フエニルエステル。 (6) ベンゾフエノン誘導体、例えば4−フエニル
ベンゾフエノン、4−フエニルベンゾフエノン
−2−カルボン酸イソオクチルエステル及び2
−ヒドロキシ−4−メトキシベンゾフエノン−
5−スルホン酸。 (7) クマリン誘導体、例えば7−ヒドロキシクマ
リン、β−ウンベリフエロン酢酸、6,7−ジ
ヒドロキシクマリン。 (8) ジガロイル−トリオレートのような没食子酸
誘導体。 (9) アリ−リデンシクロアルカノン、例えばベン
ジリデンカンフア、p−第三ブチルベンジリデ
ンカンフア(望ましい)及びメチルベンジリデ
ンカンフア。 (10) アントラニル酸メチルエステルのようなアン
トラニル酸の誘導体。 (11) ヒドロキシフエニルベンズトリアゾール。 (2)の化合物が望ましいもので、特に2−エチル
ヘキシルp−メトキシ桂皮酸エステルが望まし
い。 本発明による光遮蔽剤用に通常使われる化粧品
基剤は化粧品の必要条件を満しているなら任意の
化粧調合品を用いることができる。例えばクリー
ム、ローシヨン、乳液、軟膏、ゲル、溶液、スプ
レー、ステイツク等(GA.Nowak,「Die Kosme
−tischen Praparate」、第1版1969年、第2版、
1975年(8月)参照)。光遮蔽作用は普通、用い
た基剤にも依る。更に、同じ基剤を用いた場合光
遮蔽作用の強さは、活性物質の濃度による。光遮
蔽剤に含まれる式の化合物の適当な濃度は、1
重量%〜6重量%、望ましくは2重量%〜5重量
%の範囲である。式の化合物対紫外B線フイル
ターの比率は重要ではない。経済的理由から、例
えば式の化合物1に対し紫外B線フイルター1
〜2割合の量である。 親油性なので式の化合物は油含有及び脂肪含
有の化粧品に容易に混合することができ、これ
は、ジアニソイルメタンAのようなドイツ特許出
願2540798号(特開昭51−61641号)に開示された
構造上類似の化合物が有しないような長所であ
る。式の化合物は又、ドイツ特許出願2544180
号(特開昭52−46056号)に開示された光遮蔽剤
例えば4−イソプロピル−〔又は4−(1,1−ジ
メチルエチル)〕−ジベンゾイルメタン(B,C)
のような構造類似化合物よりも優れている。B及
びCの、脂肪溶解性は非常に良いが、紫外A線の
吸収が少ない(355nmでε=33866に比べ348nm
でε=26344又は347nmでε=27396)。式の化
合物は適当な脂肪溶解度及び紫外A線の吸収に関
し最適な特性を有する。 式の化合物は新規で、本発明の一部をなす。
これは既知の方法である、芳香族エステルと置換
アセトフエノンのクライゼン縮合でつくることが
できる(R.Hauser等、「Organic Reactions」8
巻、p59、John Wiley and Sons Inc.,New
York1954参照)。即ち式 を有する化合物を、式 (及び式中、Xはメトキシカルボニル基及
びYはアセチル基又はXはアセチル基でYはメト
キシカルボニル基である) を有する化合物と反応させてつくる。 式の化合物と式の化合物との反応は、アル
カリ金属水素化物(例えば水素化ナトリウム)、
アルカリ金属アミド(例えばナトリウムアミド)
又はアルカリ金属アルコラート(例えばナトリウ
ムメチラート又はナトリウムエチラート)のよう
な強塩基の存在下でおこなうと良い。 反応はエーテル類(例えばテトラヒドロフラ
ン)又は炭化水素(例えばトルエン)のような不
活性溶媒の存在下でおこなうと良い。反応温度は
約20℃〜70℃、特に約50℃がよい。 式の化合物の分離は、氷及び酸(例えば鉱酸
又は酢酸のようアルカンカルボン酸)を、固体沈
殿物として分離している式の化合物の金属塩に
加えておこない、こうして遊離した式の化合物
は、有機相を濃縮して得ることが望ましい。 必要なら、式の化合物を低級アルコール(例
えばメタノール又はエタノール)からの再結晶で
更に精製することができる。 次の諸例は本発明により供する光遮蔽剤の説明
である。 例 1
The present invention relates to light shielding agents. It is known that sunlight accelerates the aging of the skin and that this undesirable effect is initially caused by the direct tanning of the skin by ultraviolet A-rays having a wavelength in the range of about 320 nm to 40 nm. According to the invention, 4-(1,1-dimethylethyl)-
4'-Methoxydibenzoylmethane, i.e. the formula Compounds with are excellent ultraviolet A filters,
It was found to significantly prevent skin aging and to have excellent skin tolerance and stability (light, heat and moisture). According to the invention, the maximum absorption of a compound of formula is approximately
330nm to 360nm, but not 290nm to 320nm, but in this range of about 290nm to 320nm, the compound of formula was also found to improve. The present invention is based on the above findings and one aspect relates to a light-screening agent comprising a compound of the above formula, preferably in combination with an ultraviolet B filter. Another feature of the invention relates to the use of the compounds of the formula in light screening agents, preferably in conjunction with ultraviolet B filters. If the light shielding agent contains a compound of the formula along with an ultraviolet B filter, it will completely absorb ultraviolet rays in the range of 280 nm to 380 nm (so-called "A+B complete shielding").
and protect the skin from premature aging and often photodermatitis. The production of the light-screening agents according to the invention, in particular the skin protection preparations for everyday cosmetics, is carried out by mixing the compounds of the formula, preferably in combination with an ultraviolet B-ray filter, into customary cosmetic bases for light-screening agents. UV B-ray filters within the scope of the invention, i.e. about
As substances having maximum absorption between 290 nm and 320 nm, organic compounds belonging to the following various substance classes can be cited as general ultraviolet B-ray filters. (1) p-aminobenzoic acid derivatives, such as ethyl p-aminobenzoate, and other esters (p-
propyl aminobenzoate, butyl p-aminobenzoate, isobutyl p-aminobenzoate, etc.) ethyl p-dimethylaminobenzoate, p-
Glyceryl aminobenzoate and amyl p-dimethylaminobenzoate. (2) Cinnamic acid derivatives, such as 2-ethoxyethyl p
- Methoxycinnamic acid ester, 2-ethylhexyl p-methoxycinnamic acid ester, p-methoxycinnamic acid ester mixture and cinnamic acid ester mixture. (3) Dibenzaladin. (4) Heterocyclic nitrogen-containing compounds, such as 2-phenylbenzimidazole derivatives (eg 2-phenylbenzimidazole-5-sulfonic acid). (5) Salicylic acid derivatives, such as salicylic acid menthyl ester, salicylic acid homomenthyl ester, and salicylic acid phenyl ester. (6) Benzophenone derivatives, such as 4-phenylbenzophenone, 4-phenylbenzophenone-2-carboxylic acid isooctyl ester and 2-carboxylic acid isooctyl ester.
-Hydroxy-4-methoxybenzophenone-
5-Sulfonic acid. (7) Coumarin derivatives, such as 7-hydroxycoumarin, β-umbelliferone acetic acid, 6,7-dihydroxycoumarin. (8) Gallic acid derivatives such as digalloyl-triolate. (9) Arylidenecycloalkanones such as benzylidene camphor, p-tert-butylbenzylidene camphor (preferred) and methylbenzylidene camphor. (10) Derivatives of anthranilic acid, such as anthranilic acid methyl ester. (11) Hydroxyphenylbenztriazole. The compound (2) is preferred, and 2-ethylhexyl p-methoxycinnamate is particularly preferred. The cosmetic base commonly used for the light-screening agent according to the invention can be any cosmetic formulation, provided it meets the cosmetic requirements. For example, creams, lotions, emulsions, ointments, gels, solutions, sprays, stickers, etc. (GA. Nowak, “Die Kosme
-tischen Praparate”, 1st edition 1969, 2nd edition,
(See August 1975). The light-shielding effect usually also depends on the base material used. Furthermore, the strength of the light-shielding effect when using the same base depends on the concentration of active substance. A suitable concentration of a compound of formula in the light screening agent is 1
It ranges from 2% to 5% by weight, preferably from 2% to 5% by weight. The ratio of compound of formula to ultraviolet B filter is not critical. For economic reasons, for example, for compound 1 of the formula, 1 ultraviolet B filter
~2% amount. Being lipophilic, the compounds of the formula can be easily mixed into oil- and fat-containing cosmetics, such as dianisoylmethane A, which is disclosed in German Patent Application No. 2540798. This is an advantage that structurally similar compounds do not have. The compound of the formula is also registered in German patent application 2544180
For example, 4-isopropyl-[or 4-(1,1-dimethylethyl)]-dibenzoylmethane (B, C)
superior to structurally similar compounds such as The fat solubility of B and C is very good, but the absorption of ultraviolet A rays is low (at 355 nm, ε = 348 nm compared to 33866).
at ε=26344 or ε=27396 at 347 nm). The compounds of the formula have optimal properties with respect to adequate fat solubility and absorption of UV A radiation. The compounds of formula are new and form part of the present invention.
It can be prepared by a known method, Claisen condensation of an aromatic ester and a substituted acetophenone (R. Hauser et al., "Organic Reactions" 8.
Volume, p59, John Wiley and Sons Inc., New
(see York 1954). That is, the expression A compound with the formula (In the formula, X is a methoxycarbonyl group and Y is an acetyl group, or X is an acetyl group and Y is a methoxycarbonyl group.) The reaction between a compound of formula and a compound of
Alkali metal amides (e.g. sodium amide)
Alternatively, it may be carried out in the presence of a strong base such as an alkali metal alcoholate (for example, sodium methylate or sodium ethylate). The reaction is preferably carried out in the presence of an inert solvent such as an ether (eg, tetrahydrofuran) or a hydrocarbon (eg, toluene). The reaction temperature is preferably about 20°C to 70°C, particularly about 50°C. The separation of the compound of formula is carried out by adding ice and an acid (e.g. a mineral acid or an alkane carboxylic acid such as acetic acid) to the metal salt of the compound of formula which is separated as a solid precipitate, and the compound of formula thus liberated is , it is desirable to obtain by concentrating the organic phase. If necessary, compounds of formula can be further purified by recrystallization from lower alcohols such as methanol or ethanol. The following examples are illustrative of light screening agents provided by the present invention. Example 1

【表】 Aの成分を混ぜ、水浴上で加熱し85℃にし、こ
の度でBを加える。混合物Cを75℃に加熱し、A
及びBの混合物に加える。25℃〜35℃に冷却後、
水分が失われていたら補い、Dを加える。
[Table] Mix ingredients A, heat on a water bath to 85℃, and add B at this time. Heat mixture C to 75°C and
and B to the mixture. After cooling to 25℃~35℃,
Replenish any moisture lost and add D.

【表】【table】

【表】 混合物Aを水浴で80℃に加熱する。Alugelを室
温でパラフイン油に分散し、この混合物を撹拌
し、大きな粒子を完全になくす。次にBをAに加
え撹拌し、均一溶液にする。Cを75℃〜80℃に加
熱する。勢いよく撹拌しながら、CをAとBの混
合物に加える。25℃〜30℃に冷却後、蒸発水分を
補い、Dを加える。生じた混合物を均質化する。
[Table] Heat mixture A to 80°C in a water bath. Disperse the Alugel in paraffin oil at room temperature and stir the mixture to completely eliminate large particles. Next, add B to A and stir to make a homogeneous solution. Heat C to 75°C to 80°C. Add C to the mixture of A and B while stirring vigorously. After cooling to 25°C to 30°C, compensate for evaporated water and add D. Homogenize the resulting mixture.

【表】 混合物Aを水浴上で80℃〜85℃に加熱し、この
温度でBをその中に溶解する。混合物Cを前以つ
て75℃に加熱しておき、A及びBの混合物に加え
る。25℃〜30℃に冷却した後、失われた水分を補
い、Dを加える。混合物を更に撹拌し、温度を25
℃〜30℃にする。
Table: Mixture A is heated on a water bath to 80° C. to 85° C. and at this temperature B is dissolved therein. Mixture C is preheated to 75°C and added to the mixture of A and B. After cooling to 25°C to 30°C, replace the lost moisture and add D. Stir the mixture further and reduce the temperature to 25
Bring the temperature to between ℃ and 30℃.

【表】 混合物Aを蒸気浴で85℃に加熱し、そしてこの
温度でBを加える。Cの成分を混合し75℃に加熱
し、A及びBの混合物に加える。25℃〜30℃に冷
却した後、失われた水を補い、それからDを加え
る。混合物を更に撹拌し、温度を25℃〜30℃に下
げる。 次の例は式の化合物の製造の説明である。 例 2 (a) p−第3ブチル安息香酸356g(2モル)、メ
チルアルコール243g(7.6モル)及び硫酸(96
%)35gを、スターラーと凝縮器をつけた四ツ
口丸底フラスコに入れる。混合物をゆつくり撹
拌しながら8時間還流する。凝縮器を蒸留塔に
かえ、過剰のメチルアルコールを蒸留して除
き、終りにわずかに減圧になるが、100℃以上
にならないようにする。混合物を冷却し、氷の
上に注ぐ。相を分離し、有機相を氷水、氷を入
れた飽和炭酸ナトリウム溶液で洗浄し、最後に
氷で中性になるまで洗う。有機相を硫酸ナトリ
ウムで乾燥し、このようにして沈殿物が393g
得られる。ウイドマー精留塔(120mm)を用い
て蒸留すると沸点76℃/0.02mmHgのエステル
345g(収率90%)が得られる。 (b) 完全に乾燥し、窒素を流した丸底フラスコに
ナトリウムアミド(50%トルエン懸濁液)85g
(1.1モル)及びイソプロピルエーテル180gを
加え、そこにイソプロピルエーテル180g中に
アセチルアニソール150.2g(1モル)を溶か
した溶液を50℃〜60℃の温度で滴下する。すぐ
に反応が始まり白色のペースト状の固まりが生
じる。添加が完全に終つたら、混合物を更に30
分間拌し、そして、p−第3ブチル安息香酸メ
チルエステル192.3gを25℃〜30℃ですばやく
加える。混合物を室温で30分、次に60℃〜70℃
で3時間撹拌し、そして12時間放置する。200
gの氷を加え、混合物を工業用塩酸128g(1.1
モル)及び氷水200mlで酸性にする。混合物を
生成物のナトリウム塩が溶解するまで撹拌す
る。相が分離するので、有機相を氷水で中性に
なるまで洗う。有機相を回転蒸発器で濃縮する
と、イソプロピルエーテル290gが回収され
る。粗生成物は347gで溶媒を含んでいる。メ
タノールからの再結晶で、4−(1,1−ジメ
チルエチル)−4′−メトキシジベンゾイルメタ
ン199.8g(64.5%)が得られ、融点は83.5℃で
ある。 (c) 80%のナトリウムアミド36g(1.2モル)及
び300gの乾燥トルエンを窒素を流した丸底フ
ラスコに入れる。混合物を50℃に加熱し、
150.2g(1モル)のアセチルアニソールを309
gのトルエンに溶解したものを1.5時間以内で
加える。添加終了後、混合物を15分間50℃に保
ち、次にこの温度で、192.3g(1モル)のp
−第3ブチル安息香酸メチルエステルを1時間
50分以内で加える。混合物を50℃で1時間更に
撹拌し、生成物が固体沈殿物として分離した
後、100℃で1時間加熱する。混合物を12時間
放置し、そこからそこに300mlの氷水、次に100
mlの純粋な塩酸及び250mlの氷水の混合物を加
える。相が分離するので、有機相を水で2度洗
う。有機相を硫酸ナトリウムで乾燥し、同時に
20gの活性炭素で処理する。過後、液を結
晶化が始まるまで濃縮する。ヘキサン50ml加
え、混合物を冷却し、ブフナー漏斗で過す
る。600mlのメタノールから再結晶すると、4
−(1,1−ジメチルエチル)−4′−メトキシジ
ベンゾイルメタンが総収量220.91g(71.2%)
得られ、融点は83.5℃である。
Table: Mixture A is heated to 85° C. in a steam bath and B is added at this temperature. Mix ingredients of C, heat to 75°C and add to mixture of A and B. After cooling to 25°C to 30°C, replace the lost water and then add D. The mixture is further stirred and the temperature is lowered to 25°C to 30°C. The following example is an illustration of the preparation of a compound of formula. Example 2 (a) 356 g (2 mol) of p-tert-butylbenzoic acid, 243 g (7.6 mol) of methyl alcohol and sulfuric acid (96 mol)
%) into a four-necked round-bottomed flask equipped with a stirrer and condenser. The mixture is refluxed for 8 hours with gentle stirring. Replace the condenser with a distillation column and remove excess methyl alcohol by distilling it off. The pressure will be slightly reduced at the end, but the temperature should not exceed 100℃. Cool the mixture and pour over ice. The phases are separated and the organic phase is washed with ice water, saturated sodium carbonate solution with ice and finally with ice until neutral. The organic phase was dried with sodium sulfate, thus leaving 393 g of precipitate.
can get. When distilled using a Widmer rectifier (120 mm), an ester with a boiling point of 76°C/0.02 mmHg is produced.
345 g (90% yield) are obtained. (b) 85 g of sodium amide (50% suspension in toluene) in a completely dry, nitrogen-flushed round bottom flask.
(1.1 mol) and 180 g of isopropyl ether are added thereto, and a solution of 150.2 g (1 mol) of acetyl anisole dissolved in 180 g of isopropyl ether is added dropwise at a temperature of 50°C to 60°C. The reaction begins immediately and a white paste-like mass forms. Once the addition is complete, add another 30 g of the mixture.
Stir for a minute and then quickly add 192.3 g of p-tert-butylbenzoic acid methyl ester at 25°C to 30°C. Heat the mixture at room temperature for 30 minutes, then at 60°C to 70°C
Stir for 3 hours and leave for 12 hours. 200
g of ice was added and the mixture was dissolved in 128 g (1.1 g) of industrial hydrochloric acid.
mol) and acidify with 200 ml of ice water. The mixture is stirred until the sodium salt of the product is dissolved. The phases separate and the organic phase is washed with ice water until neutral. The organic phase is concentrated on a rotary evaporator and 290 g of isopropyl ether are recovered. The crude product weighs 347 g and contains solvent. Recrystallization from methanol gives 199.8 g (64.5%) of 4-(1,1-dimethylethyl)-4'-methoxydibenzoylmethane, melting point 83.5°C. (c) 36 g (1.2 moles) of 80% sodium amide and 300 g of dry toluene are placed in a round bottom flask flushed with nitrogen. Heat the mixture to 50°C,
150.2g (1 mol) of acetylanisole in 309
g dissolved in toluene is added within 1.5 hours. After the addition was complete, the mixture was kept at 50°C for 15 minutes and then at this temperature 192.3 g (1 mol) of p.
-Tertiary butylbenzoic acid methyl ester for 1 hour
Add within 50 minutes. The mixture is further stirred at 50° C. for 1 hour, and after the product has separated out as a solid precipitate, it is heated at 100° C. for 1 hour. Let the mixture stand for 12 hours, then add there 300 ml of ice water, then 100 ml of ice water
Add a mixture of ml pure hydrochloric acid and 250 ml ice water. The phases separate and the organic phase is washed twice with water. Dry the organic phase with sodium sulfate and simultaneously
Treat with 20g activated carbon. After filtration, the liquid is concentrated until crystallization begins. Add 50 ml of hexane, cool the mixture and filter through a Buchner funnel. When recrystallized from 600ml of methanol, 4
-(1,1-dimethylethyl)-4'-methoxydibenzoylmethane total yield 220.91g (71.2%)
obtained, with a melting point of 83.5°C.

Claims (1)

【特許請求の範囲】 1 4−(1,1−ジメチルエチル)−4′−メトキ
シジベンゾイルメタン。 2 4−(1,1−ジメチルエチル)−4′−メトキ
シジベンゾイルメタンを含む紫外線吸収用遮光
剤。 3 4−(1,1−ジメチルエチル)−4′−メトキ
シジベンゾイルメタンを使う場合に紫外B線フイ
ルターを併用する、特許請求の範囲第2項記載の
遮光剤。 4 式 を有する化合物と式 (式及びにおいて、Xはメトキシカルボニ
ル基及びYはアセチル基、又はXがアセチル基及
びYがメトキシカルボニル基を示す) を有する化合物とを反応させることを特徴とす
る、4−(1,1−ジメチルエチル)−4′−メトキ
シジベンゾイルメタンの製造方法。
[Claims] 1 4-(1,1-dimethylethyl)-4'-methoxydibenzoylmethane. 2. A UV-absorbing light-shielding agent containing 4-(1,1-dimethylethyl)-4'-methoxydibenzoylmethane. 3. The light shielding agent according to claim 2, wherein an ultraviolet B filter is used when 4-(1,1-dimethylethyl)-4'-methoxydibenzoylmethane is used. 4 formula Compounds and formulas with 4-(1,1- A method for producing (dimethylethyl)-4'-methoxydibenzoylmethane.
JP14637979A 1978-11-13 1979-11-12 44*1*11dimethylethyl**4**methoxydibenzoylmethane and said manufacture Granted JPS5566535A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1163978A CH642536A5 (en) 1978-11-13 1978-11-13 Sunscreen agents

Publications (2)

Publication Number Publication Date
JPS5566535A JPS5566535A (en) 1980-05-20
JPS6116258B2 true JPS6116258B2 (en) 1986-04-28

Family

ID=4375415

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14637979A Granted JPS5566535A (en) 1978-11-13 1979-11-12 44*1*11dimethylethyl**4**methoxydibenzoylmethane and said manufacture

Country Status (2)

Country Link
JP (1) JPS5566535A (en)
CH (1) CH642536A5 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008533188A (en) * 2005-03-21 2008-08-21 フエルレル インターナショナル,ソシエダッド アノニマ Benzoate compounds, compositions, uses and methods relating thereto
JP2008542459A (en) * 2005-05-27 2008-11-27 ロレアル Method for photostabilizing dibenzoylmethane derivatives using merocyanine sulfone derivatives; photoprotective cosmetic compositions comprising said combination

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5962517A (en) * 1982-10-04 1984-04-10 Shiseido Co Ltd Anti-suntan cosmetic
JPS61215309A (en) * 1985-03-20 1986-09-25 Shiseido Co Ltd External agent for skin
JPH0662398B2 (en) * 1985-03-20 1994-08-17 株式会社資生堂 External skin preparation
JPH0645532B2 (en) * 1985-03-20 1994-06-15 株式会社資生堂 External skin preparation
LU86703A1 (en) * 1986-12-08 1988-07-14 Oreal PHOTOSTABLE COSMETIC COMPOSITION CONTAINING A UV-A FILTER AND A UV-B FILTER, ITS USE FOR PROTECTING THE SKIN AGAINST UV RAYS AND A METHOD OF STABILIZING THE UV-A FILTER WITH THE UV-B FILTER
JPS6429303A (en) * 1987-07-24 1989-01-31 Shiseido Co Ltd Skin external preparation
GB8925473D0 (en) * 1989-11-10 1989-12-28 Unilever Plc Sunscreen compositions
ATE212536T1 (en) 1994-10-14 2002-02-15 Hoffmann La Roche LIGHT STABLE COSMETIC SUNSCREEN PRODUCTS
US5840282A (en) * 1995-06-21 1998-11-24 Givaudan-Roure (International) Sa Light screening compositions
US6033649A (en) * 1995-12-18 2000-03-07 Roche Vitamins Inc. Light screening agents
CN103261140B (en) * 2010-12-20 2016-04-06 帝斯曼知识产权资产管理有限公司 The manufacture method of dibenzoylmethane derivative

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008533188A (en) * 2005-03-21 2008-08-21 フエルレル インターナショナル,ソシエダッド アノニマ Benzoate compounds, compositions, uses and methods relating thereto
JP2008542459A (en) * 2005-05-27 2008-11-27 ロレアル Method for photostabilizing dibenzoylmethane derivatives using merocyanine sulfone derivatives; photoprotective cosmetic compositions comprising said combination

Also Published As

Publication number Publication date
JPS5566535A (en) 1980-05-20
CH642536A5 (en) 1984-04-30

Similar Documents

Publication Publication Date Title
US4387089A (en) 4-(1,1-Dimethylethyl)-4'-methoxydibenzoylmethane
US4584190A (en) Novel chalcone derivatives and ultraviolet absorbers comprising the same
CA1338561C (en) Aromatic esters and thioesters; process for preparing the same and their use in human or animal medecine and in cosmetics
US4562067A (en) Preparation of novel dibenzoylmethane derivative sunscreen agents
CA1204779A (en) 3-benzylidene camphors; process for preparing the same and their use as protective agents against uv radiation
JP3233451B2 (en) Aromatic compounds derived from imine, process for producing the same, and cosmetic compositions containing the same
US5175340A (en) New liposoluble unsaturated benzalmalonate derivatives and their use as absorbers for ultraviolet radiation in cosmetics
JPS6116258B2 (en)
EP0260162A1 (en) Bicyclic aromatic derivatives, process for their preparation and their use as medicines
CA1315674C (en) Pharmaceutical compositions containing at least one bicyclic aromatic derivative as an active ingredient
IE59768B1 (en) Novel chromophores, sunscreen compositions and methods for preventing sunburn
CA2021329C (en) Di-aromatic esters, process for their preparation and use in human or veterinary medicine and as cosmetic compositions
EP0977749A1 (en) Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same
LU85139A1 (en) NOVEL 3-BENZYLIDENE CAMPHOR DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS PROTECTIVE AGENTS AGAINST UV RAYS AND AS MEDICAMENTS
US4584191A (en) Hair care and skin care compositions containing biotin ethyl ester
CA1312333C (en) Strontium salt, its preparation process and the pharmaceutical compositions containing it
EP0461958A1 (en) 2-(aminoalkyl)-5-(arylalkyl)1,3-dioxanderivatives their production and their use in therapeutics
US5146002A (en) Aroyl ketone derivative, uv ray absorber comprising the same, and cosmetic composition containing the same
US20040152912A1 (en) Thermally stable ferulic acid derivatives
CA1312865C (en) Aromatic derivatives of butyric acid, their preparation process and their use as cosmetics as well as in human and veterinary medicine
US5191121A (en) Aroyl ketone derivative, UV ray absorber comprising the same, and cosmetic composition containing the same
JPH11236328A (en) Cosmetic comprising hydrochalcone derivative and/or chalcone derivative as active ingredient
JPS5824512A (en) Sunscreen composition
JP2000507227A (en) Cinnamylidene camphor derivatives and their use as UV-A protective agents
EP0409729B1 (en) Bi-aromatic thioesters, process for their preparation and their use in human or veterinary medicine and in cosmetics